The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Head-to-head comparison of 68Ga-PSMA-11 PET/CT and mpMRI in the detection, intra-prostatic localization, and local extension of primary prostate cancer: A single-center imaging study with histopathology gold-standard.
 
Ida Sonni
No Relationships to Disclose
 
Ely Felker
No Relationships to Disclose
 
Andrew Thomas Lenis
No Relationships to Disclose
 
Anthony E Sisk
No Relationships to Disclose
 
Shadfar Bahri
No Relationships to Disclose
 
Martin S. Auerbach
No Relationships to Disclose
 
Wesley R Armstrong
No Relationships to Disclose
 
Voraparee Suvannarerg
No Relationships to Disclose
 
Teeravut Tubtawee
No Relationships to Disclose
 
Tristan Grogan
No Relationships to Disclose
 
David Elashoff
No Relationships to Disclose
 
Johannes Czernin
Stock and Other Ownership Interests - SOFIE; Trethera
Consulting or Advisory Role - Advanced Accelerator Applications
 
Steven Raman
No Relationships to Disclose
 
Robert Evan Reiter
Stock and Other Ownership Interests - ImaginAb
Consulting or Advisory Role - Astellas Pharma (I)
Speakers' Bureau - Genomic Health; ImaginAb; Janssen
Patents, Royalties, Other Intellectual Property - patents surrounding discovery of PSCA and N-cadherin, owned by UCLA (Inst)
 
Jeremie Calais
Honoraria - Advanced Accelerator Applications; Progenics; Radiomedix
Consulting or Advisory Role - Blue Earth Diagnostics; Curium Pharma; GE Healthcare; Janssen; Progenics; Telix Pharmaceuticals